Description
The determination of specific antigens CA 125 and CA 72-4 allows for the detection of malignant ovarian neoplasms, preclinical disease recurrence, and the evaluation of the efficacy of chemotherapeutic treatment or surgical intervention.
Period of execution
By 00:00 the next day. The specified time does not include the day of biomaterial collection
Biomaterial type